178 related articles for article (PubMed ID: 8896415)
41. Epstein-Barr virus in gastric carcinoma in Suzhou, China and Osaka, Japan: association with clinico-pathologic factors and HLA-subtype.
Qiu K; Tomita Y; Hashimoto M; Ohsawa M; Kawano K; Wu DM; Aozasa K
Int J Cancer; 1997 Apr; 71(2):155-8. PubMed ID: 9139835
[TBL] [Abstract][Full Text] [Related]
42. Molecular analysis of latent membrane protein 1 in patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Japan.
Tabata YHibi S; Teramura T; Kuriyama K; Yagi T; Todo S; Sawada T; Imashuku S
Leuk Lymphoma; 2000 Jul; 38(3-4):373-80. PubMed ID: 10830744
[TBL] [Abstract][Full Text] [Related]
43. Nucleotide sequences and functions of the Epstein-Barr virus latent membrane protein 1 genes isolated from salivary gland lymphoepithelial carcinomas.
Jen KY; Higuchi M; Cheng J; Li J; Wu LY; Li YF; Lin HL; Chen Z; Gurtsevitch V; Fujii M; Saku T
Virus Genes; 2005 Mar; 30(2):223-35. PubMed ID: 15744579
[TBL] [Abstract][Full Text] [Related]
44. [C-terminal 30 bp-deletion mutation of latent membrane protein 1 gene of Epstein-barr virus in non-hodgkin's lymphoma].
Liu JR; Lin Q; Wu XY
Ai Zheng; 2005 Feb; 24(2):145-8. PubMed ID: 15694022
[TBL] [Abstract][Full Text] [Related]
45. Analysis of LMP1 variants of EBV in Southern Thailand: evidence for strain-associated T-cell tropism and pathogenicity.
Saechan V; Mori A; Mitarnun W; Settheetham-Ishida W; Ishida T
J Clin Virol; 2006 Jun; 36(2):119-25. PubMed ID: 16616610
[TBL] [Abstract][Full Text] [Related]
46. Deletion of Epstein-Barr virus latent membrane protein 1 gene in Japanese and Brazilian gastric carcinomas, metastatic lesions, and reactive lymphocytes.
Hayashi K; Chen WG; Chen YY; Murakami I; Chen HL; Ohara N; Nose S; Hamaya K; Matsui S; Bacchi MM; Bacchi CE; Chang KL; Weiss LM
Am J Pathol; 1998 Jan; 152(1):191-8. PubMed ID: 9422536
[TBL] [Abstract][Full Text] [Related]
47. Difference of Epstein-Barr virus isolates from Japanese patients and African Burkitt's lymphoma cell lines based on the sequence of latent membrane protein 1.
Kanai K; Satoh Y; Saiki Y; Ohtani H; Sairenji T
Virus Genes; 2007 Jan; 34(1):55-61. PubMed ID: 16917741
[TBL] [Abstract][Full Text] [Related]
48. Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts.
Brooks L; Yao QY; Rickinson AB; Young LS
J Virol; 1992 May; 66(5):2689-97. PubMed ID: 1313894
[TBL] [Abstract][Full Text] [Related]
49. AIDS-related lymphoma in Brazil. Histopathology, immunophenotype, and association with Epstein-Barr virus.
Bacchi CE; Bacchi MM; Rabenhorst SH; Soares FA; Fonseca LE; Barbosa HS; Weiss LM; Gown AM
Am J Clin Pathol; 1996 Feb; 105(2):230-7. PubMed ID: 8607450
[TBL] [Abstract][Full Text] [Related]
50. Genome-Wide Analysis of Epstein-Barr Virus Isolated from Extranodal NK/T-Cell Lymphoma, Nasal Type.
Lin N; Ku W; Song Y; Zhu J; Lu Z
Oncologist; 2019 Sep; 24(9):e905-e913. PubMed ID: 30940744
[TBL] [Abstract][Full Text] [Related]
51. Frequency of a 30-base pair deletion in the latent membrane protein-1 gene in Epstein-Barr virus-associated lymphomas in Japan.
Hirose Y; Masaki Y; Kurose N
Int J Hematol; 2000 Aug; 72(2):210-5. PubMed ID: 11039671
[TBL] [Abstract][Full Text] [Related]
52. Epstein-Barr virus and Hodgkin's disease: a comparative immunological, in situ hybridization, and polymerase chain reaction study.
Lauritzen AF; Hørding U; Nielsen HW
APMIS; 1994 Jul; 102(7):495-500. PubMed ID: 7917218
[TBL] [Abstract][Full Text] [Related]
53. Geographic sequence variation of latent membrane protein 1 gene of Epstein-Barr virus in Hodgkin's lymphomas.
Lin JC; Lin SC; Luppi M; Torelli G; Mar EC
J Med Virol; 1995 Feb; 45(2):183-91. PubMed ID: 7775937
[TBL] [Abstract][Full Text] [Related]
54. The role of Epstein-Barr virus in the pathogenesis of Hodgkin's disease.
Niedobitek G
Ann Oncol; 1996; 7 Suppl 4():11-7. PubMed ID: 8836403
[TBL] [Abstract][Full Text] [Related]
55. Epstein-Barr virus coinfection and recombination in non-human immunodeficiency virus-associated oral hairy leukoplakia.
Walling DM; Clark NM; Markovitz DM; Frank TS; Braun DK; Eisenberg E; Krutchkoff DJ; Felix DH; Raab-Traub N
J Infect Dis; 1995 May; 171(5):1122-30. PubMed ID: 7751686
[TBL] [Abstract][Full Text] [Related]
56. Epstein-Barr virus infection and associated products (LMP, EBNA2, vIL-10) in nodal non-Hodgkin's lymphoma of human immunodeficiency virus-negative Japanese.
Ohshima K; Suzumiya J; Tasiro K; Mukai Y; Tanaka T; Kato A; Kikuchi M
Am J Hematol; 1996 May; 52(1):21-8. PubMed ID: 8638607
[TBL] [Abstract][Full Text] [Related]
57. Presence of Epstein-Barr virus and strain type assignment in Argentine childhood Hodgkin's disease.
Preciado MV; De Matteo E; Diez B; Menárguez J; Grinstein S
Blood; 1995 Nov; 86(10):3922-9. PubMed ID: 7579362
[TBL] [Abstract][Full Text] [Related]
58. Sequence variation in the Epstein-Barr virus latent membrane protein 1.
Miller WE; Edwards RH; Walling DM; Raab-Traub N
J Gen Virol; 1994 Oct; 75 ( Pt 10)():2729-40. PubMed ID: 7931159
[TBL] [Abstract][Full Text] [Related]
59. Molecular epidemiology of deletions and mutations of the latent membrane protein 1 oncogene of the Epstein-Barr virus in posttransplant lymphoproliferative disorders.
Smir BN; Hauke RJ; Bierman PJ; Gross TG; d'Amore F; Anderson JR; Greiner TC
Lab Invest; 1996 Oct; 75(4):575-88. PubMed ID: 8874388
[TBL] [Abstract][Full Text] [Related]
60. Epstein-Barr virus latent gene expression in primary effusion lymphomas containing Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8.
Horenstein MG; Nador RG; Chadburn A; Hyjek EM; Inghirami G; Knowles DM; Cesarman E
Blood; 1997 Aug; 90(3):1186-91. PubMed ID: 9242551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]